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Abstract
Background: The effectiveness of a 2015–17 community intervention to reduce cardiovascular disease (CVD) and
type 2 diabetes (T2DM) risk factors is assessed in a Sri Lanka adult population, using a before-and-after study design.
Methods: Four contiguous Public Health Midwife (PHM) areas in Kalutara district (Western Province) were exposed to
a Sri Lankan designed community health promotion initiatives (without screening) to lower CVD and T2DM risk
factors. Pre- and post-intervention surveys (2014, n = 1,019; 2017, n = 908) were of 25–64 year males (M) and females
(F) from dissimilar randomly selected clusters (villages or settlements) from PHMs, with probability of selection
proportional to population size, followed by household sampling, then individual selection to yield equal-probability
samples. Differences in resting blood pressure (BP), fasting plasma glucose (FPG), total cholesterol, body mass index
and tobacco smoking, adjusting for cluster sampling, age and socio-economic differences, were examined.
Results: Hypertension prevalence declined from 25% to 16% (F) (p <.0001), and 21% to 17% (M). Both mean systolic
and diastolic BP declined. T2DM declined from 18% to 13% (F), and 18% to 15% (M), as did mean fasting plasma
glucose. Elevated total cholesterol declined from 21% to 15% in women (p = 0.003) and mean cholesterol declined.
Frequency distributions, medians and means of these continuous CVD risk factors shifted to lower levels, and were
mostly statistically significant (p < 0.05).
Conclusions: Community health promotion can lower key CVD and T2DM risk factors. Lowering tobacco
consumption in males and obesity remain challenges in Sri Lanka.
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Background
During the past century Sri Lanka has experienced
declines in rates of infectious disease mortality in women,
leading to reduction in total female mortality and contin-
ued improvement in female life expectancy. By contrast,
the absolute decline in infectious disease mortality in men
has been accompanied by increased cardiovascular dis-
ease (CVD) mortality, leading to a prolonged plateau in
male life expectancy [1]. The increasing burden of non-
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communicable diseases (NCD) in low- and to middle-
income countries (LMIC) in the 21st Century, such as Sri
Lanka, constitutes an aspect of the epidemiological tran-
sition experienced by developed countries half a century
previously.
According to the World Health Organization (WHO),
such shifts in disease profile require corresponding
changes in health care systems, from a focus on infectious
diseases to a more comprehensive model that includes
NCD prevention and care [2]. Moreover, WHO has advo-
cated a shift from expensive, treatment-focused models
toward more affordable preventive and health promotion
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measures, with less emphasis on the high-risk approach
and more stress on a population approach [3, 4].
Three main risk factors for elevated incidence and mor-
tality of atherosclerotic CVD – hypertension, and elevated
blood cholesterol and tobacco smoking – were established
by cohort studies, particularly the Framingham study, [5]
the Seven Countries study, [6] and the British Doctors
Study, [7, 8] amongst others. From the 1970s, mortality
rates from atherosclerotic CVD in many affected coun-
tries declined following elucidation of these risk factors,
along with diabetes and elevated plasma glucose, and their
causes in diet (excess saturated fat, salt and energy intake),
tobacco smoking, and inadequate physical activity with
obesity as an important intermediary. This has been fur-
ther supported by studies of the effects of risk factor
reduction in individuals and groups, [9–11] and in whole
populations, [12, 13] leading to declines in CVDmortality,
with the Finnish North Karelia Project a prominent and
successful example [14].
Control of NCDs involves both the population approach
involving prevention through decreasing risk factors by
health promotion and structural changes directed at
the entire population, [4, 15, 16] and the individual
high-risk approach involving detection and management
of cases at high risk. The WHO update on primary
health care (PHC) in 2008 emphasised inter alia pro-
motion of healthier lifestyles, [17] exemplified by the
“Best Buys” approach. This derives ultimately from the
first WHO report on community control of cardio-
vascular disease published in 1984, [18] and on other
work by Geoffrey Rose, [19] aimed at those at moderate
and high risk of CVD. In addition, the WHO devel-
oped the Package of Essential Non-communicable disease
interventions (PEN) approach for developing countries,
using high risk CVD detection from testing, and com-
parison with (hypothetical) regional multi-risk charts,
and treatment through primary health care medical
facilities.
The PHC setting in LMICs plays an important role
in NCD prevention and control [20–22] because of the
proximity of PHC and community health care workers
to local communities, and their distribution in both rural
and urban areas [23, 24]. With the decline in infectious
disease and under-nutrition, and the shift of much of pre-
mature mortality from < 5 years to adult ages, there is a
need to re-orient PHC prevention and control to include
the major causes of morbidity and premature mortality.
This has changed in many populations to cardiovascular
disease, diabetes and other chronic conditions in adults,
while preserving important maternal and child health ini-
tiatives, and nutrition and environmental health priorities.
In Sri Lanka, several risk factor prevalence sample sur-
veys for NCD have been undertaken, [25, 26] although
comparisons are difficult because of variations in age
groups and rural/urban compositions of those surveyed.
Tobacco smoking has changed little (around 30% in
men, <1% in women), mean BMI appears to be increas-
ing in both sexes, and blood pressure (BP) and hyper-
tension (HT) also appear to be increasing, with HT
prevalence recently estimated at 25% [27]. Measures of
fasting blood glucose (FBG) and prevalence of T2DM
(8.5–24%) have been highly variable, [28] and are par-
ticularly sensitive to the rural/urban composition of the
survey samples.
Current programs to address CVD risk factors in Sri
Lanka are influenced by the development of Healthy
Lifestyle Centres (HLC), initiated by the Ministry of
Health (MoH) and the Japan International Cooperation
Agency (JICA) from 2008–2013. HLCs numbered 826 by
2016, [29] and (anecdotally) 900 by 2018 [30]. Men and
women aged 35–65 years are encouraged to attend, and
following self-referral are screened for BP, FBG and body
mass index (BMI), with lifestyle assessment and coun-
selling provided on physical exercise, diet, tobacco use
and alcohol consumption. No baseline studies were per-
formed in areas prior to the HLC initiative, and current
monitoring is limited to self-presenters. Comparisons of
HLC attendees with the broader population are inconclu-
sive, [29] and the effectiveness of the HLC approach based
on voluntary counselling and testing remains unevalu-
ated. The HLCs have considerably lower male than female
attendance rates [31].
A large proportion of resources for controlling NCD
in Sri Lanka, under the 2010 NCD strategic framework,
has been expended on secondary and tertiary care, [31]
including: increased NCDmedication supplies in primary
care facilities; and increased specialised facilities and
numbers of doctors and specialists with training in NCD
diagnosis and treatment. In contrast, health resources
committed to NCD prevention have not been as fully
implemented, including: promotion of population-wide
healthy lifestyle programmes; media-advocacy campaigns
to reduce intake of salt, sugar, fat; and implementation of
the healthy school canteen policy. Physician informants
to the report [31] also noted that “most of the NCD
money was not directed to evidence-based ‘best buys’ for
reducing and managing NCDs”.
To examine if a population-based health promotion
approach is feasible and could be successful in decreas-
ing NCD risk factors, a population intervention in the
Western Province of Sri Lanka was conducted from 2014
to 2017 to reduce risk factors for atherosclerotic CVD in
areas without HLCs, using a Sri Lankan designed commu-
nity health promotion approach through primary health
care and CHWs. The objective of the intervention was to
shift population frequency distributions of CVD risk fac-
tors to lower levels, and to reduce means and prevalences
of these CVD risk factors.
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Methods
Health promotion intervention
The campaign of community health promotion used
established networks of primary health care workers
(PHCW), and was initiated in 2015 after the first Kalutara
risk factor survey (2014). The community interventions
were designed by senior local investigators (LG, SN1 and
PdeS), based on an extensive review of pilot CVD pre-
vention programs in Sri Lanka, and on their detailed
knowledge of previous successful community engagement
in healthcare in the country. NoHLCs were located within
the study area during the study period. Public health mid-
wives (PHM) were enlisted to communicate with women
concerning the need to reduce CVD, T2DM, and risk fac-
tors. PHMs organised meetings in venues commonly used
for public gatherings. Suitable women were invited to a
community clinic centre and involved in an awareness
program to reduce dietary salt, sugar and animal fat, and
promote physical activity, run by local medical officers,
nurses and public health inspectors.
The participating women acted as change agents to
influence others in the community, with whom they could
easily communicate, including other opinion leaders [32].
Each of the four PHM areas was instructed to recruit at
least 20 change agents. As the PHM areas varied in size,
between 80 and 100 change agents in total were recruited.
Women were consciously selected for recruiting women
as change agents since in Sri Lanka they are more involved
than men in shopping, cooking, child and extended family
care, household planning, and similar activities. Education
sessions (> 10) led by these women were then held, with
20–40 participants in each session.
NCD prevention messages were integrated into PHM
home visit services and into fortnightly PHM outreach
community clinics routinely conducted for immunisation,
antenatal care, children’s growth monitoring, and simi-
lar activities. PHMs spend at least 15 days per month on
home visits and 3–4 days in the clinics in their area. Reg-
ular monthly in-service training programs for PHMs now
include sessions pertaining to NCD.
As part of the intervention, a health and lifestyle car-
nival was held in Kalutara on 4 July 2015 and attended
by approximately 2,500 people of all ages. The carni-
val showcased various community activities to promote
healthy lifestyles. Stalls demonstrated cooking of differ-
ent traditional foods, and recipes were given to attendees.
Street theatre and exercise demonstrations were featured,
and plays performed by pre-schoolchildren promoting
healthy lifestyles. BP and anthropometric measurements
were available on request.
The intervention was implemented continuously over
2015–17. Throughout the intervention health messages
were sent frequently to the entire community via different
media, primarily print and face-to-face. Particular focus
was placed on women to take up local sports (e.g., elle,
a Sri Lankan game similar to baseball). Health promo-
tion messages were kept simple and directed specifically
at lowering proximate NCD risk factors such as reduc-
tion of added salt in cooking, lessening dietary intake of
animal fat, quitting tobacco smoking, etc. Much of the
preventive interventions were implemented through and
by women who are particularly concerned with diet and
food preparation.
The health promotion intervention involved trained
community health workers, utilising the existing primary
healthcare network, along with influential members of the
local community, who provided face-to-face verbal dis-
semination of preventive information both to individuals
(e.g. in clinical settings, opportunistically or purposively)
and to groups (e.g. in purposive public gatherings); pro-
vision of printed material on healthy eating (especially
reduction of salt and saturated fat intake), and on regular
physical activity; and inserting prevention messages into
entertainment settings (e.g. the carnival). This approach
aimed to maximise the reach and appeal of the health
promotion interventions across different population seg-
ments.
Monitoring of risk factors
Sampling
For the community health promotion interventions, four
contiguous PHM areas (estimated 25–64 year popula-
tion at the 2012 census of 8,100) were selected as the
study site from within the Kalutara Health area. Identi-
cal random sampling methods were employed for both
surveys to produce dissimilar clusters and individuals,
but to ensure representative and comparable samples.
To monitor the consequences of the intervention, vil-
lage or settlement clusters were randomly selected from
each PHM area, with a probability of selection of each
proportional to population size, followed by household
sampling, then individual selection (Kish grid method),
[33] to yield equal-probability samples of approximately
1,000 adults for the 2014 and 2017 surveys. For each sur-
vey, 8 clusters (of 24 available) were randomly selected
from PHM area Bombuwala I (2012 Census adults 25-64
years=2,021, sample=250); 8 (of 19) from Bombuwala II
(2012 Census adults=2,106, sample=250); 6 (of 21) from
Gamgoda (2012 Census adults=1,307, sample =200); and
10 (of 10) from Nagoda (2012 Census adults=2,577,
sample=300). Actual samples were: 2014 survey, 1,019
(sampling fraction 12.7%), and 2017 survey, 908 (sam-
pling fraction 11.3%), based on 2012 census estimates for
adults 25-64 years resident in the 4 PHM areas. Subjects
examined in both surveys were excluded from analyses
(n = 23). Samples were randomly selected to be repre-
sentative of the study population for the before-and-after
comparison.
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Data Collection
Data were collected as in the first survey, where further
details can be found [26]. On the day preceding the survey,
participants were recruited and advised to fast overnight.
Questionnaires using a modified WHO STEPS survey
instrument were administered by trained staff (Step 1),
with physical (Step 2), and biochemical measurements
(Step 3) taken. TheWHO questionnaire was administered
in Sinhalese (its translation from English was verified
by back-translation by independent translators). Height,
weight, and waist circumference were measured once.
Obesity was defined as body mass index (BMI) 27.5
kg/m2 (Asian) (WHO standard) [34].
Respondents were seated for 10 minutes before three
blood pressure readings were taken, with 3–5 minute
intervals between measurements. Mean systolic blood
pressure SBP and diastolic blood pressure DBP were cal-
culated from the first two BP readings if the difference
between them was < 10 mm Hg, or from the second and
third readings if the difference was greater. Hypertension
was signified by SBP 140 mm Hg or DBP 90 mm Hg
or if the participant had been taking anti-hypertensive
medication in the previous two weeks [35].
In the 2014 baseline survey, fasting plasma glucose FPG
was measured using a Roche ACCU-CHEK glucose meter
with supplied test strips, calibrated to provide plasma glu-
cose equivalent measurements from capillary whole blood
samples [26]. In the follow-up survey (2017) glucose was
measured in whole capillary blood samples by a Major
Bio II glucose meter with supplied test strips, uncalibrated
to plasma levels, so the readings were multiplied by 1.11
to correspond to a plasma concentration reading [36]. To
allow for systematic differences found between glucose
meters, FPG readings of the second 2017 survey were
inflated by a further factor of 1.07. T2DM was defined as
FPG 7.0 mmol/L or taking medication for T2DM in the
previous 2 weeks [37].
Total plasma cholesterol was measured on capillary
whole blood by supplied test strips using a Roche
Accutrend Plus cholesterol meter in the 2014 survey, and a
Mission Ultra cholesterol meter (Acon Labs), in 2017. Ele-
vated (‘high’) total plasma cholesterol was defined as> 6.2
mmol/L (based on current clinical practice [38]), consis-
tent with Rose [1992], [39] or taking medication for high
cholesterol in the previous 2 weeks.
Participants with elevated absolute CVD risk factor
results (30% probability of a CVD event over 10 years)
according to WHO multi-risk charts applicable to Sri
Lanka [40] were advised according to Sri Lanka MoH
guidelines to attend the local health facility for follow-
up. All data were recorded using a standardized survey
form, coded and entered into EpiData software [41]. Data
were validated by re-checking with the original survey
forms. Ethics approval was obtained from the National
Institute of Health Sciences Ethics Review Committee
prior to commencement of the study. All participants pro-
vided informed verbal consent to participate in the survey
before any measurements were obtained.
Analysis
Inter-survey differences in mean in systolic and diastolic
blood pressures, fasting plasma glucose, total choles-
terol and body mass index are compared using t-tests.
Inter-survey differences in prevalences of HT, T2DM/high
FPG, high total cholesterol and obesity are compared
using chi-squared statistics, and odds ratios estimated
from logistic regression. Analyses are adjusted for clus-
ter sampling, and age, using the combined survey age
strata as the weighting standard, or from regression based
on individual data. Age differences between surveys are
minimal (Table 1), but age is included as a universal
confounder. Means and prevalence ratios are addition-
ally adjusted for income and education (using linear and
logistic regression) since the baseline study showed some
socio-economic associations with CVD risk factors [26].
Differences in median values were tested by the two-
sample median test, and differences in frequency dis-
tributions by the Kolmogorov-Smirnov test, using SAS
(version 9.4).
Results
After excluding those participating in both surveys (n =
23), there are 1,018 from the first survey (606 women,
412 men), and 885 from the second survey (613 women,
272 men). There are minimal, non-significant differences
between mean ages in the two surveys (Table 1). Some
differences in the socio-economic status of the samples
were evident, where the respondents in the second sur-
vey tended to have higher income and education lev-
els (see Appendix, Table 4). Despite these differences,
the results for high BP, FPG and total cholesterol were
similar across these socioeconomic strata. (Appendix,
Table 5). Survey differences in income and education
levels, along with age, were controlled for in statistical
analyses.
Blood pressure and hypertension
Among women in the second survey, mean SBP was 120
compared to 124 mmHg in the first survey. After adjust-
ing for sampling design effects, this difference was − 4.14
mmHg; after additional adjustment for age, the differ-
ence was − 3.2 mmHg (p =0.0010), and − 2.8 mmHg
after further adjustment for income and education levels
(p = 0.0015) (Table 1). Mean female DBP in the sec-
ond survey was 71 compared to 74 mmHg in the first
survey. The cluster- and age-adjusted difference of − 2.0
mmHg was statistically significant (p <.0001), with a
similar result after additional adjustment for income and
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Table 1 Mean age, systolic and diastolic blood pressures, fasting plasma glucose, total cholesterol and body mass index in adults aged
25–64 years, by sex and survey, Kalutara, Sri Lanka
Risk Factor Sex First Survey (2014) Second Survey (2017) Decrease P-value
Age (yr) F 43.0 (41.9 – 44.2) 41.7 (40.5 – 43.0) 1.31 (2.70 – +0.08) 0.0641
M 41.6 (40.4 – 42.7) 41.5 (39.9 – 43.1) 0.08 (1.78 – +1.62) 0.9266
Systolic blood F 123.9 (121.9 – 125.8) 119.8 (118.3 – 121.2) 4.14 (6.31 – 1.96) 0.0003
pressure (mmHg) Adjusted:a 3.19 (5.04 – 1.34) 0.0010
Adjusted:b 2.83 (4.54 – 1.12) 0.0015
M 125.2 (123.3 – 127.1) 124.3 (121.7 – 126.9) 0.88 (4.04 – +2.30) 0.5814
Adjusted:a 0.84 (3.98 – +2.29) 0.5918
Adjusted:b 2.08 (4.90 – +0.74) 0.1447
Diastolic blood F 73.5 (72.6 – 74.4) 71.2 (70.4 – 71.9) 2.32 (3.36 – 1.28) <.0001
pressure (mmHg) Adjusted:a 2.03 (2.93 – 1.13) <.0001
Adjusted:b 2.01 (2.94 – 1.08) 0.0001
M 72.4 (71.2 – 73.6) 71.2 (69.5 – 72.8) 1.24 (3.16 – +0.68) 0.2019
Adjusted:a 1.22 (3.20 – +0.76) 0.2226
Adjusted:b 2.04 (4.00 – 0.07) 0.0431
Fasting plasma F 6.39 (6.21 – 6.57) 5.68 (5.51 – 5.85) 0.71 (0.95 – 0.47) <.0001
glucose (mmol/L) Adjusted:a 0.67 (0.91 – 0.43) <.0001
Adjusted:b 0.63 (0.88 – 0.38) <.0001
M 6.34 (6.12 – 6.57) 5.74 (5.57 – 5.92) 0.60 (0.88 – 0.32) <.0001
Adjusted:a 0.60 (0.88 – 0.31) <.0001
Adjusted:b 0.72 (1.06 – 0.39) <.0001
Total F 5.56 (5.38 – 5.74) 4.91 (4.82 – 4.99) 0.66 (0.86 – 0.45) <.0001
cholesterol (mmol/L) Adjusted:a 0.63 (0.84 – 0.42) <.0001
Adjusted:b 0.60 (0.84 – 0.34) <.0001
M 5.50 (5.34 – 5.66) 5.03 (4.91 – 5.15) 0.47 (0.66 – 0.29) <.0001
Adjusted:a 0.47 (0.66 – 0.28) <.0001
Adjusted:b 0.50 (0.75 – 0.25) 0.0002
Body mass F 24.8 (24.5 – 25.1) 25.4 (25.0 – 25.7) +0.58 (+0.72 – +1.08) 0.0256
index (kg/m2) Adjusted:a +0.59 (+0.64 – +1.11) 0.0284
Adjusted:b +0.40 (0.11 – +0.91) 0.1180
M 23.1 (22.6 – 23.5) 23.7 (23.0 – 24.3) +0.57 (0.12 – +1.25) 0.1051
Adjusted:a +0.56 (0.11 – +1.23) 0.0980
Adjusted:b +0.06 (0.67 – +0.79) 0.8628
M = males; F = females. First survey 2014 (n = 412 M, 606 F); Second survey 2017 (n = 272 M, 613 F)
Means and 95% CIs adjusted for cluster sampling (by village/settlement)
aMean difference adjusted for age and cluster sampling by linear regression
bMean difference adjusted for age, cluster sampling, education level and income by linear regression
Bolded results: significant at p0.05.
Note: analyses exclude subjects who participated in both surveys (n = 23)
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education level. Men showed less decline in mean SBP
(0.9 mmHg), but after adjustment for age, education and
income the decline was 2.1 mmHg (p > 0.05); similarly
for DBP, the unadjusted decline of 1.2 mmHg in men and
was 2.0 mmHg after adjustment for income and education
levels, but was statistically significant (p =0.0431).
Between the two surveys, HT prevalence (SBP140
mm Hg or DBP90 mm Hg or taking anti-hypertensive
medication [35]) declined from 25% to 16% in women,
with a prevalence ratio of 0.65 adjusted for age and clus-
ter sampling (p <.0001); and from 21% to 17% in men
with a prevalence ratio of 0.79 (p > 0.05) (Table 2). Fur-
ther adjustment for income and education using logistic
regression gave odds ratios for HT in women of 0.56
(p =0.0002) and 0.63 (p =0.0410) for men, both statisti-
cally significant.
In women, the lower BP frequency distributions in the
second survey compared to the first were significant (SBP
p =0.0068; DBP p =0.0023), as well as the lower medians
for SBP (p =0.0482) and DBP (p =0.0004). In men, fre-
quency distributions and medians were lower in the sec-
ond survey compared to the first, but only the difference
in median DBP was statistically significant (p =0.0314)
(see Table 3 and Figures 1 and 2 in Appendix) .
Fasting plasma glucose and diabetes
Among women in the first survey, mean FPG was 6.39
compared to 5.68 mmol/L in the second survey; in men
mean FPG was 6.34 compared to 5.74 mmol/L (Table 1).
After adjusting for sampling design effects, age, income
and education, the mean differences in FPG levels were
lower by − 0.63 mmol/l (p <.0001) in women and − 0.72
mmol/l (p <.0001) in men.
Prevalence of high FPG/T2DM (T2DM was defined as
FPG7.0 mmol/L or taking medication for T2DM [37])
declined from 18% in the first survey to 14% in the second
in women, with a clustering-sampling adjusted prevalence
ratio of 0.71 (p = 0.0011); and from 18% to 15% in men
with a prevalence ratio of 0.87 (p = 0.5380) (Table 2).
With additional adjustment for age, income and educa-
tion level, the OR of high FPG/T2DM was 0.70 in women
(p = 0.0754) and 0.70 in men (p = 0.2112).
Comparison of the two surveys showed a clear shift in
the FPG distributions to lower values in both women and
men (Figure 3 in Appendix). The differences in the fre-
quency distributions and medians of FPG in women and
men were significant (p <.0001) (Table 3).
Blood cholesterol
Significantly lower mean total cholesterol was found in
the second compared to the first survey for both sexes;
by − 0.47 mmol/l (men) and − 0.66 mmol/l (women)
(both p <.0001), adjusted for cluster sampling; and
by 0.50 mmol/l and 0.60 mmol/l respectively when
further adjusted for income and education level (p =
0.0002,<.0001 respectively, Table 1).
Prevalence of elevated total blood cholesterol (> 6.2
mmol/L or takingmedication for high cholesterol [38, 39])
declined in women from 21% to 15% from the first to
the second survey with a cluster-sampling adjusted preva-
lence ratio of 0.71 (p = 0.0011), but without significant
change in men (19% to 20%, prevalence ratio = 1.07, p >
0.05) (Table 2). After also adjusting for age, income and
education level, the OR for women was 0.65 (p = 0.0040),
and for men was 0.95 (p > 0.05).
The frequency distributions of total blood cholesterol in
both men and women showed lower values in the second
survey compared to the first, and were significantly dif-
ferent (p <.0001) for both sexes (Table 3 and Figure 4 in
Appendix).
Bodymass index and obesity
The slightly higher (unadjusted) mean and median BMI in
both sexes in the second compared to the first survey were
no longer statistically significantly different (in women)
when adjusted for income and education. Formen, slightly
higher mean and median BMI at the second survey was
not statistically significant, unadjusted or adjusted. The
higher obesity odds ratios and prevalences in the second
survey were not statistically significant.
Tobacco smoking
Prevalence of current tobacco smoking of < 1% in women
and 28–29% in men were similar in each survey, and not
statistically significantly different.
Discussion
This study assessed the effectiveness of a Sri Lankan
designed and implemented health promotion initiative to
reduce risk factors for CVD, implemented continuously
over 2015–17 targeting an adult population aged 25–64
years in a part of Kalutara District in theWestern Province
of Sri Lanka. The intervention aimed to alter diet (sat-
urated fat, salt, energy), increase physical activity, and
reduce tobacco smoking; and was assessed by measure-
ment of CVD risk factors by mini-STEPS surveys of dif-
ferent subjects in 2014 prior to the intervention, [26] and
after three years of implementation, in 2017. The measur-
able objective of the intervention was to shift frequency
distributions of CVD risk factors to reduce numbers in the
population at high and moderate risk of CVD (since risk is
continuous). Considerable CVD cases and deaths emanate
from those at moderate risk (below accepted diagnostic
high-risk cut-offs), as well as from those at high risk whose
numbers in the population are much fewer. This observa-
tion was made by Geoffrey Rose, [19] and incorporated in
the first WHO Expert Committee on control of CVD in
1984 [18].
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Table 2 Prevalences (%), with prevalence and odds ratios of hypertension, type 2 diabetes, high total cholesterol, obesity and smoking
status by survey, adults aged 25–64 years, males and females, Kalutara, Sri Lanka
Risk Factor Sex First Second Second:First survey P-value
Survey Survey Prevalence/Odds ratio
Hypertension F 24.7 16.1 0.65 (0.51 – 0.84) 0.0002
Adjusted ORa 0.53 (0.40 – 0.70) <.0001
Adjusted ORb 0.56 (0.42 – 0.75) 0.0002
M 21.1 16.6 0.79 (0.56 – 1.10) 0.1557
Adjusted ORa 0.75 (0.49 – 1.15) 0.1816
Adjusted ORb 0.63 (0.40 – 0.98) 0.0410
Diabetes F 18.2 13.5 0.74 (0.53– 1.04) 0.0859
Adjusted ORa 0.71 (0.48 – 1.03) 0.0721
Adjusted ORb 0.70 (0.48 – 1.04) 0.0754
M 17.5 15.2 0.87 (0.55 – 1.38) 0.5380
Adjusted ORa 0.84 (0.48 – 1.46) 0.5264
Adjusted ORb 0.70 (0.40 – 1.23) 0.2112
High total cholesterol F 21.5 15.2 0.71 (0.58 – 0.87) 0.0011
Adjusted ORa 0.62 (0.49 – 0.79) 0.0002
Adjusted ORb 0.65 (0.49 – 0.87) 0.0040
M 18.9 20.1 1.07 (0.79 – 1.45) 0.6740
Adjusted ORa 1.05 (0.73 – 1.51) 0.7880
Adjusted ORb 0.95 (0.65 – 1.39) 0.7782
Obesity F 25.6 28.7 1.12 (0.95 – 1.32) 0.1744
Adjusted ORa 1.18 (0.96 – 1.46) 0.1220
Adjusted ORb 1.13 (0.89 – 1.44) 0.3015
M 11.3 14.4 1.27 (0.95 – 1.71) 0.1129
Adjusted ORa 1.35 (0.96 – 1.90) 0.0874
Adjusted ORb 1.19 (0.82 – 1.72) 0.3656
Current smoker F 0.29 0.14 0.49 (0.04 – 5.56) 0.5410
Adjusted ORa 0.55 (0.05 – 5.56) 0.6109
Adjusted ORb - -
M 29.1 27.7 0.95 (0.71 – 1.27) 0.7301
Adjusted ORa 0.97 (0.64 – 1.47) 0.8891
Adjusted ORb 1.19 (0.84 – 1.69) 0.3172
Daily smoker F 0.29 0.14 0.49 (0.04 – 5.56) 0.5410
Adjusted ORa 0.55 (0.05 – 5.56) 0.6109
Adjusted ORb - -
M 20.4 19.9 0.98 (0.65 – 1.47) 0.9146
Adjusted ORa 1.01 (0.60 – 1.70) 0.9725
Adjusted ORb 1.32 (0.79 – 2.21) 0.2865
M = males; F = females. First survey 2014 (n = 412 M, 606 F); Second survey 2017 (n = 272 M, 613 F)
Prevalence ratio adjusted for cluster sampling (by village/settlement)
aOdds ratios (ORs) adjusted for age and cluster sampling
bOdds ratios (ORs) adjusted for age, cluster sampling, income and education levels
Hypertension: SBP140 mmHg or DBP90 mmHg or taking medication for high BP
Diabetes/High FPG: Fasting plasma glucose7 mmol/l or taking medication for T2DM
High cholesterol: total cholesterol > 6.2 mmol/l or taking medication for high cholesterol
Obesity: body mass index27.5 kg/m2
Smoking: smoking tobacco – manufactured or hand-rolled cigarettes, cigars or pipe
Bolded results: significant at p0.05.
Note: analyses exclude subjects who participated in both surveys (n = 23)
Given its limited resources, Sri Lanka has an enviable
history of a strong and effective primary health care net-
work. Through most of last century Sri Lanka was able
to significantly reduce infant and child mortality [42] and
maternal mortality, [43] using primary care midwifery.
Although PHMs still play an important role in antenatal
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Table 3 Medians of systolic and diastolic blood pressures, fasting plasma glucose, total cholesterol and body mass index in adults
aged 25–64 years, by sex and survey, Kalutara, Sri Lanka
Risk Factor Sex First Second Decrease P-value of P-value of
Survey Survey median distribution
(2014) (2017) differencea differenceb
Systolic blood F 119.5 118.0 1.50 0.0482 0.0068
pressure (mmHg) M 124.0 122.5 1.50 0.1415 0.2249
Diastolic blood F 73.0 70.0 3.00 0.0004 0.0023
pressure (mmHg) M 72.0 70.0 2.00 0.0314 0.1590
Fasting plasma F 5.89 5.23 0.29 <.0001 <.0001
glucose (mmol/L) M 5.89 5.30 0.30 <.0001 <.0001
Total F 5.35 4.76 0.59 <.0001 <.0001
cholesterol (mmol/L) M 5.33 4.84 0.49 <.0001 <.0001
Body mass F 24.6 25.5 +0.98 0.0099 0.0160
index (kg/m2) M 23.1 23.2 +0.13 0.8514 0.9387
M = males; F = females
First survey 2014 (n = 412 M, 606 F); Second survey 2017 (n = 272 M, 613 F)
aMedian differences are unadjusted and tested by two-sample median test
bDistribution differences (unadjusted) tested by Kolmogorov-Smirnov test
Bolded results: significant at p0.05
Note: analyses exclude subjects who participated in both surveys (n = 23)
care and pregnancy risk assessment, almost all pregnant
women now deliver in hospital. Consequently, PHM roles
have been broadened to encompass a life course approach
to ongoing healthcare provision, with NCD prevention
made more integral to that from this intervention. The
question thus arises: can the strengths in the primary
care system be harnessed, as occurred in this interven-
tion, to reduce CVD risk factors and thus CVDmortality?
The results reported here provide evidential support for
a Sri Lankan designed, community-based, whole popula-
tion intervention approach for reducing CVD and T2DM
risk factors, implemented by primary care workers with
strong community links to local ‘change agents’.
While evaluations of individual-based health promotion
interventions to lower NCD risk factors have been fre-
quent in developed countries, evidence is emerging from
corresponding population-based interventions to prevent
NCD in LMIC settings. A systematic review of controlled
trials of health promotion interventions to reduce NCD
risk factors led by community health workers (CHW) in
LMICs, conducted in Egypt, India, Iran, Pakistan, Thai-
land, China, Nigeria, Ghana, South Africa, Costa Rica,
Mexico and American Samoa, showed significant reduc-
tions in SBP and DBP in individuals followed longitu-
dinally [44]. Of the seventeen trial studies included in
the review, six targeted the general community and 11
targeted high-risk populations. Four of those targeting the
general population had BP, fasting glucose, BMI or total
cholesterol outcomes [45–48]. Interventions were con-
ducted by community health workers and/or primary care
physicians, one of which incorporated a 2× 2 factorial
study design of CHWs and/or physicians [48]. For BP, lon-
gitudinal changes in intervention versus control groups
favoured the intervention groups for SBP, ranging from
− 9 mmHg to − 0.89 mmHg, but not all were statisti-
cally significant. Results were somewhat different for DBP,
ranging from +2.22 mmHg to − 3.95 mmHg, with some
statistically significant and the positive DBP difference
coming from a single study. Other studies of community-
based health promotion interventions not included in
the review also showed similar results in favour of the
intervention, for example that of Jafar et al. [2009] [49].
While our results for SBP and DBP are of a some-
what similar magnitude to these studies, they are not
directly comparable since they are cross-sectional differ-
ences (in different individuals) before-and-after the inter-
vention rather than differences in longitudinal changes (in
the same individuals) between those contemporaneously
exposed and not exposed to the interventions.
The approach, where differences in population CVD
risk factors from STEPS or similar surveys of differ-
ent individuals from the same population conducted at
different time points, is used in to infer secular changes
in CVD risk factors in the population overall, is the usual
method of assessment of population interventions for pri-
mary prevention of CVD, and is implicit in the WHO
intermittent STEPS methodology.
Comparable programs and interventions implemented
in the WHOWestern Pacific region targeting community
prevention and control of NCD have had varying degrees
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of success [50–52]. Schultz et al. [2011], in their review
of a community-based intervention to address obesity
in the Pacific, argued that local leadership and owner-
ship, and having skills and infrastructure available locally,
were critical to the success of community-based inter-
ventions, and their absence a reason for failure in past
programs [52]. The present study did not impose a pre-
designed approach from elsewhere, which adds weight to
the findings of Schultz et al.
Several NCD prevention programs have targeted CVD
and T2DM risk factors in Sri Lanka over the last decade.
The HLCs, comprising > 900 centres by 2018, [30] mostly
are attached to hospitals, with some attached to commu-
nity health facilities. No HLCs were located within the
study area of the present study. The effectiveness of HLCs
in reduction of risk factors in the surrounding population
is unclear and needs evaluation.
The maintenance and continued reduction in CVD
risk factors found in the present study will depend on
the extent that community-based interventions become
embedded in the PHC system and local behavioural cul-
ture. Attribution of the observed changes evidenced in the
present study would be enhanced by a Stepped Wedge
study design [53].
A strength of this study is that it consists of a defined
population, and that the baseline and follow-up surveys
(sampling fractions 11–12%) were from randomly selected
villages/settlements providing different subjects minimis-
ing possible Hawthorne effects from previous testing [54].
Furthermore, the unexposed group was truly unexposed
to the intervention because the intervention had not
occurred when surveyed. Thus contamination from the
intervention in control groups was precluded which is
always possible in contemporaneous exposed and unex-
posed comparisons. A disadvantage of the study is the lack
of non-intervention control areas for contemporaneous
comparison. However, this study was designed to pre-test
a community primary health care intervention using exist-
ing staff, which could be then assessed in a larger cluster
randomised investigation including risk factor testing and
control arms using a Stepped Wedge design.
To determine that the findings before and after the inter-
ventions were not due to significantly differing samples,
the analyses were repeated for only those villages ran-
domly selected for both surveys. Results from these 31
villages (n = 1,520) showed pre- and post-intervention
hypertension prevalences to be within 1–2 percentage
points of corresponding estimates from the total sample
(cf. Table 2), with similar statistically significant differ-
ences pre- and post-intervention.
A strength of the community health promotion inter-
vention was its design and implementation by the co-
authors and regional health services, with consultation
and input from local communities, using existing and
available primary care staff, with a focus on women. A sig-
nificant failure of the intervention was the lack of change
in the prevalence of tobacco smoking in men. As tobacco
smoking in Sri Lankan women remains extremely low, a
sex-specific tobacco control strategy aimed specifically at
men needs to be included in future initiatives which could
involve local environmental health officers and health
inspectors (including a significant proportion of men),
with focus on workplaces as sites for health promotion
activities.
The slightly higher mean and median BMI, and odds
ratios for obesity prevalence, in the second survey com-
pared to the first, were either not statistically significant,
or became non-significant after adjustment for education
and income, suggesting minor differences between sam-
ples; these findings cannot be further interpreted in view
of the small magnitude of differences and lack of statistical
significance.
Although an unexposed control group to compare con-
temporaneously with the intervention population before
and after the intervention would have been useful, plau-
sible causes of changes of such magnitude occurring over
a three-year intervening period are not evident, especially
given that no HLCs existed in the study areas at the time
of the first or second survey.
Conclusions
Following three years of community health promotion
initiatives and activities implemented through primary
health care in four PHM areas in the Kalutara dis-
trict of Sri Lanka, population means and prevalences
of CVD risk factors, including hypertension and blood
pressures, diabetes and fasting plasma glucose, and hyper-
cholesterolaemia and total blood cholesterol, were sig-
nificantly lower in a separate sample of adults in the
study area. Reducingmale tobacco smoking and BMI were
unchanged and remain healthcare challenges in Sri Lanka.
The main factors behind the success of this inter-
vention that could be replicated include: local health
service development and ownership of the interven-
tion, with appropriate technical collaborations; a strong
pre-existing and authoritative primary health care net-
work to initiate and integrate NCD prevention into
routine healthcare provision; use of influential ‘change
agents’ to maximise the chances of the messages of
the intervention influencing health behaviours that tar-
get as many differing segments of the population as is
feasible.
Appendix
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Fig. 1 Distribution of systolic blood pressure (SBP) at first and second risk factor surveys, Kalutara adults aged 25–64 years. Note: analyses exclude
subjects who participated in both surveys (n = 23)
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Fig. 2 Distribution of diastolic blood pressure (SBP) at first and second risk factor surveys, Kalutara adults aged 25–64 years. Note: analyses exclude
subjects who participated in both surveys (n = 23)
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Fig. 3 Distribution of fasting plasma glucose levels at first and second risk factor surveys, Kalutara adults aged 25–64 years. Note: analyses exclude
subjects who participated in both surveys (n = 23)
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Fig. 4 Distribution of total cholesterol at first and second risk factor surveys, Kalutara adults aged 25–64 years. Note: analyses exclude subjects who
participated in both surveys (n = 23)
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Table 4 Proportions (%) of respondents by sex, age group, income and education level by survey, adults aged 25–64 years, males and
females, Kalutara, Sri Lanka
Socio-demographic Females Males
Factor First Survey Second Survey First Survey Second Survey
(n = 606) (n = 412) (n = 613) (n = 272)
Age group (yr)
25–29 8.2 9.0 8.7 8.8
30–34 16.3 16.3 18.7 14.3
35–39 15.8 22.2 21.4 22.1
40–44 17.0 17.0 17.0 22.4
45–49 15.0 13.2 12.1 11.4
50–54 10.7 9.5 8.0 8.8
55–59 9.6 8.0 8.7 8.5
60–64 7.4 4.9 5.3 3.7
Education Level (yrs)
< 6 13.2 6.0 11.7 4.4
6–10 37.9 36.4 39.8 31.6
> 10 48.9 57.6 48.5 64.0
Income level (LKR)
< 20,000 54.0 27.2 50.3 18.8
20–30,000 27.8 32.2 32.8 41.9
> 30,000 18.2 40.6 16.9 39.3
Note: analyses exclude subjects who participated in both surveys (n = 23)
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Table 5 Odds ratios (age and cluster adjusted, second/first survey), of hypertension, type 2 diabetes, high total cholesterol, by income
and education levels, adults aged 25–64 years, males and females, Kalutara, Sri Lanka
Risk Factor Sex Education (yr)/ Odds ratioa P-value
Income (LKR) second/first
level survey
Hypertensionb F 5 yr 0.49 0.1778
6–10 0.47 0.0029
> 10 0.63 0.0012
M 5 0.54 0.5925
6–10 0.55 0.0920
> 10 0.79 0.3393
F 20,000 LKR 0.44 <.0001
20–30,000 0.59 0.0368
> 30,000 0.77 0.2623
M 20,000 0.35 0.0350
20–30,000 0.75 0.3525
> 30,000 0.79 0.5791
High Fasting F 5 0.69 0.4278
Plasma Glucosec 6–10 0.66 0.0732
> 10 0.70 0.3130
M 5 - -
6–10 0.83 0.6242
> 10 0.82 0.5595
F 20,000 1.05 0.7720
20–30,000 0.61 0.1987
> 30,000 0.48 0.0376
M 20,000 0.97 0.9535
20–30,000 0.65 0.2216
> 30,000 0.69 0.3065
High Fasting F 5 0.72 0.2973
Cholesterold 6–10 0.50 0.0039
> 10 0.69 0.0816
M 5 0.68 0.6042
6–10 0.89 0.7118
> 10 1.17 0.5358
F 20,000 0.78 0.1723
20–30,000 0.46 0.0097
> 30,000 0.75 0.3796
M 20,000 0.37 0.1895
20–30,000 0.77 0.3794
> 30,000 0.91 0.7752
M = males; F = females. First survey 2014 (n = 412 M, 606 F); Second survey 2017 (n = 272 M, 613 F)
aOdds ratios (ORs) adjusted for age and cluster (village) sampling
bHypertension: SBP140 mmHg or DBP90 mmHg or taking medication for high BP
cDiabetes/High FPG: Fasting plasma glucose7 mmol/l or taking medication for T2DM
dHigh cholesterol: total cholesterol > 6.2 mmol/l or taking medication for high cholesterol
Note: analyses exclude subjects who participated in both surveys (n = 23)
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Abbreviations
M: Male (or men); F: Female (or women); CVD: Cardiovascular disease; T2DM:
Type 2 diabetes; SBP: Systolic blood pressure; DBP: Diastolic blood pressure;
FPG: Fasting plasma glucose; HLC: Healthy lifestyle centre; CHW: Community
health worker; PHCW: Primary healthcare worker; LMIC: Low and middle
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